The Subject Experts Committee (SEC) has recommended Covishield to Drugs Controller General of India (DCGI) for use against COVID-19 virus in India. It was confirmed that 1.7 Lakh frontline workers will get the COVID-19 vaccine. The 10-member Subject Expert Committee of India's Central Drug Standard Control Organisation on Friday (January 1) approved emergency use authorisation of the Oxford-AstraZeneca coronavirus vaccine 'Covishield'. Also read World Health Organization lists Pfizer, BioNTech vaccine for emergency useBritain and Argentina have already authorised the vaccine for urgent public use. The UK Medicines and Healthcare products Regulatory Agency (MHRA) had earlier this week given an emergency authorisation to AstraZeneca’s covid-19 vaccine for immunising people that are 18 years or older.

Source: dna January 01, 2021 12:22 UTC